{"id":1018,"date":"2025-05-16T18:09:15","date_gmt":"2025-05-16T18:09:15","guid":{"rendered":"https:\/\/www.drrajendrananavare.in\/blogs\/?post_type=article&p=1018"},"modified":"2025-05-16T18:09:15","modified_gmt":"2025-05-16T18:09:15","slug":"multidrug-resistant-of-the-shoulder-joint-a-case-series-and-treatment-response-to-modified-all-oral-longer-regimen","status":"publish","type":"article","link":"https:\/\/www.drrajendrananavare.in\/blogs\/article\/multidrug-resistant-of-the-shoulder-joint-a-case-series-and-treatment-response-to-modified-all-oral-longer-regimen\/","title":{"rendered":"Multidrug -Resistant of the shoulder joint: A case series and treatment response to Modified all oral longer regimen"},"content":{"rendered":"—<\/span>\nPRESS NOTE
\nDate: 14\/04\/2025<\/span>\nDr. Rajendra Nanavare Publishes Groundbreaking Case Series on Rare Form of Multidrug-Resistant Tuberculosis (MDR-TB) of the Shoulder Joint<\/span>\nMumbai:
\nRenowned Chest Physician and TB expert Dr. Rajendra Tatu Nanavare has published a pioneering case series titled \u201cMultidrug-Resistant Tuberculosis of the Shoulder Joint: A Case Series and Treatment Response to Modified All-Oral Longer Regimen\u201d on his official medical blog www.drrajendrananavare.in.<\/span>\nThis landmark study documents a rare and underreported form of extrapulmonary TB affecting the shoulder joint, which posed significant diagnostic and therapeutic challenges. Through a series of clinical cases, Dr. Nanavare highlights the successful management of MDR-TB of the shoulder using WHO-recommended all-oral longer regimens, avoiding injectable drugs and their adverse effects.<\/span>\nKey contributions of the study include:<\/span>\nIdentification of rare drug-resistant TB presentations beyond the lungs<\/span>\nUse of a modified oral drug regimen, improving treatment compliance and minimizing complications<\/span>\nClinical insights into functional recovery and long-term joint outcomes<\/span>\nThis work adds a new dimension to the evolving understanding of drug-resistant TB manifestations and is especially relevant in India, where the burden of MDR-TB remains high.<\/span>\nWith over three decades of dedicated service, Dr. Nanavare has authored more than 30 scientific papers and continues to mentor postgraduate students in the field of pulmonary medicine. He currently serves as Specialty Medical Consultant at GTB Hospital, Mumbai, and is the Editorial Manager of the Indian Journal of Tuberculosis.<\/span>\nThis publication reaffirms Dr. Nanavare\u2019s commitment to advancing clinical research and improving TB care in both pulmonary and extrapulmonary domains.<\/span>\nFor more details, visit:<\/span>\n
Multidrug -Resistant of the shoulder joint: A case series and treatment response to Modified all oral longer regimen<\/a><\/span><\/blockquote>\n